Verastem (VSTM) Preferred Dividend Payments (2011 - 2012)
Verastem (VSTM) recorded quarterly Preferred Dividend Payments of $6000.0 in Q1 2012, down 57.14% quarter-over-quarter from $14000.0 in Q4 2011, and up 50.0% on a YoY basis from $4000.0 in Q2 2011.
Verastem (VSTM) Preferred Dividend Payments (2011 - 2012) Analysis & Trends
Verastem's Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $6000.0 for Q1 2012.
- In Q1 2012, Preferred Dividend Payments rose 50.0% year-over-year to $6000.0; the TTM figure through Dec 2012 stood at $6000.0 (down 81.25% YoY), while the FY2012 annual figure was $6000.0, down 81.25% from the prior year.
- Preferred Dividend Payments was $6000.0 for Q1 2012 at Verastem, down from $14000.0 in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $14000.0 in Q4 2011 to a low of $4000.0 in Q1 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2012 | 6,000.00 |
| Dec 31, 2011 | 14,000.00 |
| Sep 30, 2011 | 10,000.00 |
| Jun 30, 2011 | 4,000.00 |
| Mar 31, 2011 | 4,000.00 |